← Leaderboards
M.a. Julia Westerink
University Of Toledo Health Sci Campus
$5,825,162
Attributed
$5,825,162
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $659.4K · FY2006–20$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,825,162 · 5
VA$0 · 1
By mechanism
R01$5,353,152 · 3
R56$372,010 · 1
R41$100,000 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Streptococcus Pneumoniae”
- Jeffrey N. Weiser · New York University School Of Medicine$20,590,649
- Dallas Hughes · Novobiotic Pharmaceuticals, Llc$15,114,161
- Elaine Tuomanen · University Of Alabama At Birmingham$13,568,473
- Liise-Anne Pirofski · Yeshiva University$13,441,639
- Joseph P Mizgerd · Boston University Medical Campus$12,549,527
- Myron Max Levine · University Of Maryland Baltimore$12,500,000
Research focus
Streptococcus PneumoniaeImmunoglobulin GAgingImmunizationAffectImmune ResponseBaseVaccinesPolysaccharidesB-LymphocytesAntibodiesPneumococcal VaccinePolyvalent Pneumococcal VaccinePersonsAdultEnzyme-Linked Immunosorbent AssayMemory B-LymphocyteAntigensResponseAge-YearsPneumococcal Conjugate VaccineImmunoglobulin MIncidenceElderly
Grant awards (24)
Immune response to pneumococcal vaccination in aging renal transplant recipients$0
I01 · FY2020 · VA · contact PI
Immune response to pneumococcal vaccination in aging renal transplant recipients$0
I01 · FY2019 · VA · contact PI
Immune response to pneumococcal vaccination in aging HIV positive adults.$298,409
R01 · FY2017 · AG · contact PI
Immune response to pneumococcal vaccination in aging HIV positive adults.$298,409
R01 · FY2016 · AG · contact PI
Immune response to pneumococcal vaccination in aging HIV positive adults.$200,645
R01 · FY2015 · AG · contact PI
Immune response to pneumococcal vaccination in aging HIV positive adults.$100,000
R01 · FY2015 · AG · contact PI
Immune response to pneumococcal vaccination in aging HIV positive adults.$314,825
R01 · FY2014 · AG · contact PI
Immune Response to Pneumococcal Vaccination in HIV Infected Adults$348,510
R01 · FY2013 · AI · contact PI
Immune response to pneumococcal vaccination in aging HIV positive adults.$302,156
R01 · FY2013 · AG · contact PI
Immune Response to Pneumococcal Vaccination in HIV Infected Adults$370,755
R01 · FY2012 · AI · contact PI
Immune Response to Pneumococcal Vaccination in HIV Infected Adults$367,255
R01 · FY2011 · AI · contact PI
Immune Response to Pneumococcal Vaccination in HIV Infected Adults$374,500
R01 · FY2010 · AI · contact PI
Elderly Immune Response to Pneumococcal Polysaccharide$284,536
R01 · FY2010 · AG · contact PI
Immune Response to pneumococcal vaccination in HIV infected adults$372,010
R56 · FY2009 · AI · contact PI
Elderly Immune Response to Pneumococcal Polysaccharide$287,411
R01 · FY2009 · AG · contact PI
Elderly Immune Response to Pneumococcal Polysaccharide$287,411
R01 · FY2008 · AG · contact PI
Elderly Immune Response to Pneumococcal Polysaccharide$293,276
R01 · FY2007 · AG · contact PI
Elderly Immune Response to Pneumococcal Polysaccharide$300,054
R01 · FY2006 · AG · contact PI
ELDERLY IMMUNE RESPONSE TO PNEUMOCOCAL POLYSACCHARIDE$180,000
R01 · FY2004 · AG
ELDERLY IMMUNE RESPONSE TO PNEUMOCOCAL POLYSACCHARIDE$180,000
R01 · FY2003 · AG
A novel vaccine/adjuvant for Streptococcus pneumoniae$100,000
R41 · FY2003 · AI
ELDERLY IMMUNE RESPONSE TO PNEUMOCOCAL POLYSACCHARIDE$180,000
R01 · FY2002 · AG
ELDERLY IMMUNE RESPONSE TO PNEUMOCOCAL POLYSACCHARIDE$180,000
R01 · FY2001 · AG
ELDERLY IMMUNE RESPONSE TO PNEUMOCOCAL POLYSACCHARIDE$205,000
R01 · FY2000 · AG